Using Label Free Proteomics and RNA Sequencing to Investigate the Human Respiratory Syncytial Virus and the Effects of the Antiviral Ribavirin

Total Page:16

File Type:pdf, Size:1020Kb

Using Label Free Proteomics and RNA Sequencing to Investigate the Human Respiratory Syncytial Virus and the Effects of the Antiviral Ribavirin Using label free proteomics and RNA sequencing to investigate the human respiratory syncytial virus and the effects of the antiviral ribavirin Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy by Waleed A. Aljabr November 2016 i AUTHOR’S DECLARATION Apart from the help and advice acknowledged, this thesis represents the unaided work of the author ………………………………………………. Waleed Abdurhaman Suliman Aljabr November 2016 This research was carried out in the Department of Infection Biology and Institute of Infection and Global Health, University of Liverpool ii DEDICATION I dedicate this work to my parents who pray me constantly and inspire me. A dedication also goes to my brothers, sisters and my daughters (Leen, Almas and Yara) and my son (Luay) who were always encouraging and supportive throughout my PhD. Finally, special thanks go to my wife (Amal) for her encouragement and support during this time and for looking after my children. iii ACKNOWLEDGEMENTS In the name of Allah, the Most Gracious, the Most Merciful. All Thanks to Allah the Creator of the universe and the mastermind of everything. I would like to express my sincere gratitude to my supervisor Prof Julian Hiscox for the continuous support of my PhD study and research, for his motivation, enthusiasm, patience and wide knowledge. This work would not have been possible without the help and support of my principle supervisor. Very special thanks to my second supervisor Prof James Stuart for his support and encouragement. I am also indebted to my PhD advisors, Prof Stuart Carter and Dr Jane Hodgkinson who have been invaluable on both an academic and a personal level, for which I am extremely grateful. Appreciation also goes out to Dr Olivier for his technical support and the assistance he provided at all levels during this thesis. I must acknowledge Dr Weining Wu and Dr Diane Monday for all the instances in which their assistance helped me along the way. I would like to thank Mrs Catherine Hartley and Jenna Dawson for their support in the laboratory. Special thanks for Dr Stuart Armstrong for his help on MS-proteomic analysis. I wish to thank Centre for Genomic Research, University of Liverpool for RNA sequencing. I am also grateful to all members of the staff of Department of Infection Biology and all people in IGH, Liverpool University for being helpful during this course. I would like to thank all my colleagues back home and in the UK for encouragements. Also, I wish to thanks Hiscox’s group mates, Dr Simon Clegg and all members in Infection of Biology for being supportive and encouragements. Thanks to my sponsorship, Prince Mohammed Medical City, Ministry of Health, the Ministry of Education, in Saudi Arabia for financial support to complete the project. I appreciate the kindness for all members of the Saudi Arabia Cultural Bureau and Saudi Embassy for guidance. I would like to thanks parents, brothers and sisters for their love, care and encouragement. All my successes would not have been possible without the prayers of my mother and may Allah bless her and I ask Allah for her the paradise. Last but not least, unlimited thanks go to my wife, daughters and son for all your love, encouragement and constant support throughout this PhD journey. I would never have got through it without you. iv ABSTRACT Using label free proteomics and RNA sequencing to investigate the human respiratory syncytial virus and the effects of the antiviral ribavirin Waleed A. Aljabr Human respiratory syncytial virus (HRSV) is a known cause of severe lower respiratory tract infection (LRTI) in infants and young children worldwide. HRSV can cause illness in all ages especially those people at high risk including the immunocompromised and the elderly. Globally, HRSV infection leads to a significant healthcare and economic burden due to the lack of an approved vaccine and costly antiviral therapies that are potentially ineffective in some cases. Ribavirin is the only therapeutic licensed for the treatment of severe HRSV infection. It is a synthetic nucleoside with broad spectrum of antiviral activity encompassing both DNA and RNA viruses. The mechanism of action of ribavirin is unclear. It is thought to inhibit the replication of HRSV and lead to a reduction in viral load. How it does this is unknown and the subject of this thesis. This study focused on investigating the effect of the anti-viral ribavirin on cells in general and then infected with HRSV using both label free quantitative proteomics and transcriptomics. This allowed the investigation of the mutation frequency in HRSV and cellular protein abundance, which encompass several mechanisms by which ribavirin is postulated to work. This study was demonstrated that treatment of cells with ribavirin resulted in the increased transcription of selected cellular mRNAs including those involved in mediating anti-viral signalling. Additionally, ribavirin treatment caused a decrease in viral mRNA and proteins. In the absence of ribavirin, HRSV specific transcripts accounted for up to one third of total RNA reads from the infected cell RNA population. Ribavirin treatment resulted in a greater than 90% reduction in reads mapping to viral mRNA, while at the same time no such drastic reduction was detected for the abundance of cellular transcripts. The presented data revealed that ribavirin significantly increased the frequency of HRSV-specific RNA mutations in the viral genome, suggesting direct influence on the fidelity of the HRSV polymerase. The presented data shows transition and transversion substitutions occur during HRSV replication, and that these changes occurred in ‘hot spots’ along the HRSV genome. Examination of nucleotide substitution rates in the viral genome indicated an increase in the frequency of transition but not transversion mutations in the presence of ribavirin. In addition, the data indicated that in the continuous cell types used, and at the time points analyzed, the abundance of some HRSV mRNAs did not reflect the order in which the mRNAs were transcribed. Overall, the work describes a mechanism of action for ribavirin in the context of viral infection, that has not previously been elucidated for HRSV. v TABLE OF CONTENTS AUTHOR’S DECLARATION ii Dedication iii Acknowledgements iv Abstract v Table of contents vi List of figures x List of tables xiii List of abbreviations xiv Chapter 1: introduction 1 1.1. Classification, discovery and epidemiology 1 1.1.1. Classification 1 1.1.2. Discovery and epidemiology 3 1.2. HRSV structure, genome organisation and genomic rna 5 1.2.1 HRSV structure 5 1.2.2. Paramyxoviridae genomic organisation 7 1.2.3. The HRSV genome 8 1.3. Proteins 10 1.3.1. Envelope proteins: G, F, SH and M 10 1.3.1.1. G protein 11 1.3.1.2. F protein 11 1.3.1.3. SH protein 12 1.3.1.4. M protein 13 1.3.2. Nucleocapsid proteins: N, P, L and M2 proteins 13 1.3.3. Accessory proteins: NS1 and NS2 15 1. 4. Infectious cycle 16 1.4.1. Binding and entry 16 1.4.2. Transcription and replication of the viral genome 18 1.4.3. Assembly and budding 19 1.5. Disease pathogenesis and host-cell interactions 20 1.5.2. Disease pathogenesis 20 1.5.2.1. Factors playing a role in HRSV pathogenesis and disease outcome 21 1.5.2.1.1.Environmental and social factors 22 1.5.2.1.2 Viral factors 23 1.5.2.1.3 Host factors 24 1.5.2.1.4 Genetic factors 24 1.6. Treatments and prevention 25 1.6.1. Treatment 25 1.6.1.1. Ribavirin 25 1.6.1.2. Mechanism of action (five mechanisms) 28 1.6.1.2.1.Immunomodulatory effect 28 vi 1.6.1.2.2.Inhibition of IMPDH 28 1.6.1.2.3.Inhibition of RNA capping activity 29 1.6.1.2.4.Inhibition of viral polymerase 30 1.6.1.2.5.Loss of fitness of RNA virus genomes 30 1.6.2. Preventative therapy 31 1.7. High throughput approaches 32 1.7.1 An introduction to label free proteomics 32 1.7.2. An introduction to rna-seq 35 1.8. Research objectives 37 Chapter 2: materials and methods 39 2.1. Tissue cell culture methods 39 2.1.1. Continuous cell culture 39 2.1.2. Freezing and thawing cells 41 2.1.3. Inhibitor study 41 2.1.3.1. Ribavirin 41 2.1.3.2. 17-AAG & 17-DMAG 42 2.1.3.3. Etoposide 42 2.1.4. MTT assay 42 2.1.5. HRSV strains 43 2.1.6. Virus propagation: supernatant 43 2.1.7. Virus purification by sucrose gradient 44 2.1.8. HRSV titre determination 45 2.1.8.1. Plaque assay 45 2.1.8.2. Tissue culture infectious dose 50 (TCID50) 48 2.2. Molecular biological techniques 49 2.2.1. RNA extraction 49 2.2.2. First-strand cDNA synthesis and reverse transcription 51 2.2.3. Oligonucleotides 52 2.2.4. Measurement of DNA concentraion 54 2.2.5. Polymerase chain reachtion (PCR) for HRSV-G and GAPDH detection 54 2.2.6. Quantitative real-time RT-PCR 55 2.2.7. Agarose gel electrophoresis 56 2.2.8. Purification of DNA from gel 57 2.2.9. Total RNA-seq 58 2.3. Protein methods 59 2.3.1. Preparation of whole cell lysates 59 2.3.2. Determining protein concentration by BCA assay DETERMINING PROTEIN CONCENTRATION BY BCA ASSAY 60 2.3.3. Sodium-dodecyl sulphate polyacrylamide gel electrophoresis (SDS- PAGE) SODIUM-DODECYL SULPHATE POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE) 61 2.3.4.
Recommended publications
  • Entwicklung Einer Software Zur Identifizierung Neuartiger Und
    Entwicklung einer Software zur Identifizierung neuartiger und bekannter Infektionserreger in klinischen Proben Dissertation zur Erlangung des Doktorgrades an der Fakult¨at fur¨ Mathematik, Informatik und Naturwissenschaften Fachbereich Biologie der Universit¨at Hamburg vorgelegt von Malik Alawi Hamburg, 2020 Vorsitzender der Prufungskommission¨ Dr. PD Andreas Pommerening-R¨oser Gutachter Professor Dr. Adam Grundhoff Professor Dr. Stefan Kurtz Datum der Disputation 30. April 2021 Abstract Sequencing of diagnostic samples is widely considered a key technology that may fun- damentally improve infectious disease diagnostics. The approach can not only identify pathogens already known to cause a specific disease, but may also detect pathogens that have not been previously attributed to this disease, as well as completely new, previously unknown pathogens. Therefore, it may significantly increase the level of preparedness for future outbreaks of emerging pathogens. This study describes the development and application of methods for the identification of pathogenic agents in diagnostic samples. The methods have been successfully applied multiple times under clinical conditions. The corresponding results have been published within the scope of this thesis. Finally, the methods were made available to the scientific community as an open source bioinformatics tool. The novel software was validated by conventional diagnostic methods and it was compared to established analysis pipelines using authentic clinical samples. It is able to identify pathogens from different diagnostic entities and often classifies viral agents down to strain level. Furthermore, the method is capable of assembling complete viral genomes, even from samples containing multiple closely related viral strains of the same viral family. In addition to an improved method for taxonomic classification, the software offers functionality which is not present in established analysis pipelines.
    [Show full text]
  • Using Cell Lines to Study Factors Affecting Transmission of Fish Viruses
    Using cell lines to study factors affecting transmission of fish viruses by Phuc Hoang Pham A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Doctor of Philosophy in Biology Waterloo, Ontario, Canada, 2014 ©Phuc Hoang Pham 2014 AUTHOR'S DECLARATION I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii ABSTRACT Factors that can influence the transmission of aquatic viruses in fish production facilities and natural environment are the immune defense of host species, the ability of viruses to infect host cells, and the environmental persistence of viruses. In this thesis, fish cell lines were used to study different aspects of these factors. Five viruses were used in this study: viral hemorrhagic septicemia virus (VHSV) from the Rhabdoviridae family; chum salmon reovirus (CSV) from the Reoviridae family; infectious pancreatic necrosis virus (IPNV) from the Birnaviridae family; and grouper iridovirus (GIV) and frog virus-3 (FV3) from the Iridoviridae family. The first factor affecting the transmission of fish viruses examined in this thesis is the immune defense of host species. In this work, infections of marine VHSV-IVa and freshwater VHSV-IVb were studied in two rainbow trout cell lines, RTgill-W1 from the gill epithelium, and RTS11 from spleen macrophages. RTgill-W1 produced infectious progeny of both VHSV-IVa and -IVb. However, VHSV-IVa was more infectious than IVb toward RTgill-W1: IVa caused cytopathic effects (CPE) at a lower viral titre, elicited CPE earlier, and yielded higher titres.
    [Show full text]
  • An Open Source Bioinformatics Tool for Fast, Systematic and Cohort Based
    www.nature.com/scientificreports OPEN DAMIAN: an open source bioinformatics tool for fast, systematic and cohort based analysis of microorganisms in diagnostic samples Malik Alawi 1,2, Lia Burkhardt1, Daniela Indenbirken1, Kerstin Reumann1, Maximilian Christopeit3, Nicolaus Kröger3, Marc Lütgehetmann4, Martin Aepfelbacher4, Nicole Fischer4,5* & Adam Grundhof 1,5* We describe DAMIAN, an open source bioinformatics tool designed for the identifcation of pathogenic microorganisms in diagnostic samples. By using authentic clinical samples and comparing our results to those from established analysis pipelines as well as conventional diagnostics, we demonstrate that DAMIAN rapidly identifes pathogens in diferent diagnostic entities, and accurately classifes viral agents down to the strain level. We furthermore show that DAMIAN is able to assemble full-length viral genomes even in samples co-infected with multiple virus strains, an ability which is of considerable advantage for the investigation of outbreak scenarios. While DAMIAN, similar to other pipelines, analyzes single samples to perform classifcation of sequences according to their likely taxonomic origin, it also includes a tool for cohort-based analysis. This tool uses cross-sample comparisons to identify sequence signatures that are frequently present in a sample group of interest (e.g., a disease- associated cohort), but occur less frequently in control cohorts. As this approach does not require homology searches in databases, it principally allows the identifcation of not only known, but also completely novel pathogens. Using samples from a meningitis outbreak, we demonstrate the feasibility of this approach in identifying enterovirus as the causative agent. Nucleic acid based detection of pathogens has widely replaced culture based laboratory methods for the identif- cation of putative pathogens in samples from patients with infectious diseases1,2.
    [Show full text]
  • ERV) on Cell Culture
    Downloaded from orbit.dtu.dk on: Nov 08, 2017 Characterization of eelpout rhabdovirus (ERV) on cell culture Blomkvist, E.; Alfjorden, A.; Hakhverdyan, Mikhayil; Boutrup, Torsten Snogdal; Ahola, H.; Ljunghager, F.; Hagström, Å.; Olesen, Niels Jørgen; Juremalm, M.; Leijon, M.; Valarcher, J.-F.; Axen, C. Published in: 17th International Conference on Diseases of Fish And Shellfish Publication date: 2015 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Blomkvist, E., Alfjorden, A., Hakhverdyan, M., Boutrup, T. S., Ahola, H., Ljunghager, F., ... Axen, C. (2015). Characterization of eelpout rhabdovirus (ERV) on cell culture. In 17th International Conference on Diseases of Fish And Shellfish: Abstract book (pp. 228-228). [P-004] Las Palmas: European Association of Fish Pathologists. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. DISCLAIMER: The organizer takes no responsibility for any of the content stated in the abstracts.
    [Show full text]
  • Detection of Astrovirus in a Cow with Neurological Signs by Nanopore Technology, Italy
    viruses Article Detection of Astrovirus in a Cow with Neurological Signs by Nanopore Technology, Italy Guendalina Zaccaria 1, Alessio Lorusso 1,*, Melanie M. Hierweger 2,3, Daniela Malatesta 1, Sabrina VP Defourny 1, Franco Ruggeri 4, Cesare Cammà 1 , Pasquale Ricci 4, Marco Di Domenico 1 , Antonio Rinaldi 1, Nicola Decaro 5 , Nicola D’Alterio 1, Antonio Petrini 1 , Torsten Seuberlich 3 and Maurilia Marcacci 1,5 1 Istituto Zooprofilattico Sperimentale dell’Abruzzo e Molise, 64100 Teramo, Italy; [email protected] (G.Z.); [email protected] (D.M.); [email protected] (S.V.D.); [email protected] (C.C.); [email protected] (M.D.D.); [email protected] (A.R.); [email protected] (N.D.); [email protected] (A.P.); [email protected] (M.M.) 2 NeuroCenter, Department of Clinical Research and Veterinary Public Health, University of Bern, 3012 Bern, Switzerland; [email protected] 3 Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland; [email protected] 4 Unità Operativa Complessa Servizio di Sanità Animale, ASL Pescara, 65100 Pescara, Italy; [email protected] (F.R.); [email protected] (P.R.) 5 Dipartimento di Medicina Veterinaria, Università degli Studi di Bari, 70010 Valenzano, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0861-332440 Received: 23 April 2020; Accepted: 9 May 2020; Published: 11 May 2020 Abstract: In this study, starting from nucleic acids purified from the brain tissue, Nanopore technology was used to identify the etiological agent of severe neurological signs observed in a cow which was immediately slaughtered.
    [Show full text]
  • Comparative Evolutionary and Phylogenomic Analysis of Avian Avulaviruses 1 to 20
    Accepted Manuscript Comparative evolutionary and phylogenomic analysis of Avian avulaviruses 1 to 20 Aziz-ul-Rahman, Muhammad Munir, Muhammad Zubair Shabbir PII: S1055-7903(17)30947-8 DOI: https://doi.org/10.1016/j.ympev.2018.06.040 Reference: YMPEV 6223 To appear in: Molecular Phylogenetics and Evolution Received Date: 1 January 2018 Revised Date: 15 May 2018 Accepted Date: 25 June 2018 Please cite this article as: Aziz-ul-Rahman, Munir, M., Zubair Shabbir, M., Comparative evolutionary and phylogenomic analysis of Avian avulaviruses 1 to 20, Molecular Phylogenetics and Evolution (2018), doi: https:// doi.org/10.1016/j.ympev.2018.06.040 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Comparative evolutionary and phylogenomic analysis of Avian avulaviruses 1 to 20 Aziz-ul-Rahman1,3, Muhammad Munir2, Muhammad Zubair Shabbir3# 1Department of Microbiology University of Veterinary and Animal Sciences, Lahore 54600, Pakistan https://orcid.org/0000-0002-3342-4462 2Division of Biomedical and Life Sciences, Furness College, Lancaster University, Lancaster LA1 4YG United Kingdomhttps://orcid.org/0000-0003-4038-0370 3 Quality Operations Laboratory University of Veterinary and Animal Sciences 54600 Lahore, Pakistan https://orcid.org/0000-0002-3562-007X # Corresponding author: Muhammad Zubair Shabbir E.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • 2020 Taxonomic Update for Phylum Negarnaviricota (Riboviria: Orthornavirae), Including the Large Orders Bunyavirales and Mononegavirales
    Archives of Virology https://doi.org/10.1007/s00705-020-04731-2 VIROLOGY DIVISION NEWS 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales Jens H. Kuhn1 · Scott Adkins2 · Daniela Alioto3 · Sergey V. Alkhovsky4 · Gaya K. Amarasinghe5 · Simon J. Anthony6,7 · Tatjana Avšič‑Županc8 · María A. Ayllón9,10 · Justin Bahl11 · Anne Balkema‑Buschmann12 · Matthew J. Ballinger13 · Tomáš Bartonička14 · Christopher Basler15 · Sina Bavari16 · Martin Beer17 · Dennis A. Bente18 · Éric Bergeron19 · Brian H. Bird20 · Carol Blair21 · Kim R. Blasdell22 · Steven B. Bradfute23 · Rachel Breyta24 · Thomas Briese25 · Paul A. Brown26 · Ursula J. Buchholz27 · Michael J. Buchmeier28 · Alexander Bukreyev18,29 · Felicity Burt30 · Nihal Buzkan31 · Charles H. Calisher32 · Mengji Cao33,34 · Inmaculada Casas35 · John Chamberlain36 · Kartik Chandran37 · Rémi N. Charrel38 · Biao Chen39 · Michela Chiumenti40 · Il‑Ryong Choi41 · J. Christopher S. Clegg42 · Ian Crozier43 · John V. da Graça44 · Elena Dal Bó45 · Alberto M. R. Dávila46 · Juan Carlos de la Torre47 · Xavier de Lamballerie38 · Rik L. de Swart48 · Patrick L. Di Bello49 · Nicholas Di Paola50 · Francesco Di Serio40 · Ralf G. Dietzgen51 · Michele Digiaro52 · Valerian V. Dolja53 · Olga Dolnik54 · Michael A. Drebot55 · Jan Felix Drexler56 · Ralf Dürrwald57 · Lucie Dufkova58 · William G. Dundon59 · W. Paul Duprex60 · John M. Dye50 · Andrew J. Easton61 · Hideki Ebihara62 · Toufc Elbeaino63 · Koray Ergünay64 · Jorlan Fernandes195 · Anthony R. Fooks65 · Pierre B. H. Formenty66 · Leonie F. Forth17 · Ron A. M. Fouchier48 · Juliana Freitas‑Astúa67 · Selma Gago‑Zachert68,69 · George Fú Gāo70 · María Laura García71 · Adolfo García‑Sastre72 · Aura R. Garrison50 · Aiah Gbakima73 · Tracey Goldstein74 · Jean‑Paul J. Gonzalez75,76 · Anthony Grifths77 · Martin H. Groschup12 · Stephan Günther78 · Alexandro Guterres195 · Roy A.
    [Show full text]
  • Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson’S Disease and Huntington’S Disease
    ADVERTIMENT. Lʼaccés als continguts dʼaquesta tesi queda condicionat a lʼacceptació de les condicions dʼús establertes per la següent llicència Creative Commons: http://cat.creativecommons.org/?page_id=184 ADVERTENCIA. El acceso a los contenidos de esta tesis queda condicionado a la aceptación de las condiciones de uso establecidas por la siguiente licencia Creative Commons: http://es.creativecommons.org/blog/licencias/ WARNING. The access to the contents of this doctoral thesis it is limited to the acceptance of the use conditions set by the following Creative Commons license: https://creativecommons.org/licenses/?lang=en Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson’s disease and Huntington’s disease TESI DOCTORAL 2018 Programa de Doctorat en Neurociències Institut de Neurociències Tesi realitzada al laboratori de Malalties Neurodegeenratives de l’Institut de Recerca de la Vall d’Hebron (VHIR) Doctorand Director Tutor Sandra Franco Iborra Miquel Vila Bover José Rodríguez Álvarez Co-directora Co-directora Celine Perier Marta Martínez Vicente i AGRAÏMENTS En primer lloc vull agraïr al Miquel Vila per l’oportunitat que em va donar de començar a fer la tesi doctoral al seu lab. Gràcies per tenir sempre la porta oberta del teu despatx, per la confiança dipositada en mi i per tot el que m’has ensenyat durant tots aquests anys. A més, he tingut la sort de tenir no només un director de tesis sinó tres! Celine muchas gracias por estar siempre ahí, por ensenyarme tu manera de hacer ciencia (que me encanta!) y por ser siempre tan positiva. En mi manera de trabajar hay un poquito de ti y espero ir pasando este conocimiento a los demás porque en todo laboratorio debería ser obligatorio que hubiera alguien como tu.
    [Show full text]
  • Interacción Célula Sinovial-Fibrina Como Mecanismo Patogénico Y Oportunidad Terapéutica En Artritis Reumatoide
    UNIVERSIDAD COMPLUTENSE DE MADRID FACULTAD DE CIENCIAS QUÍMICAS DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR I TESIS DOCTORAL Interacción célula sinovial-fibrina como mecanismo patogénico y oportunidad terapéutica en artritis reumatoide MEMORIA PARA OPTAR AL GRADO DE DOCTOR PRESENTADA POR Antonio Gabucio López DIRECTORA Olga Sánchez Pernaute Madrid, 2017 © Antonio Gabucio López, 2016 Universidad Complutense de Madrid FACULTAD DE CIENCIAS QUÍMICAS TESIS DOCTORAL Interacción célula sinovial-fibrina como mecanismo patogénico y oportunidad terapéutica en artritis reumatoide PRESENTADA POR Antonio Gabucio López Facultad de Ciencias Químicas Directora Olga Sánchez Pernaute I A todos los que me han ayudado por hacer la vida más fácil y a todos los que me han “des”-ayudado por enseñarme a ser más fuerte II III AGRADECIMIENTOS A la Dra. Olga Sánchez Pernaute, directora del estudio, por su incansable apoyo y asesoramiento científico. Al doctor Gabriel Herrero-Beaumont Cuenca, jefe de servicio de reumatología de la Fundación Jiménez Díaz, por su insustituible apoyo y sin el cual, esta tesis no hubiera sido posible. A los pacientes anónimos, objeto y objetivo del estudio, sin cuya existencia y solidaridad nada de esto tendría sentido. A la Sociedad Española de Reumatología, por el apoyo prestado en el origen de este proyecto. A la Fundación Conchita Rábago de Jiménez Díaz por su soporte financiero. A todas aquellas personas que de una u otra manera han contribuido al desarrollo de esta tesis doctoral. IV V ÍNDICE RESUMEN / ABSTRACT..............................................................................................
    [Show full text]
  • Aplicación De La Biología De Sistemas Al Estudio De La Malaria Y Búsqueda De Biomarcadores Y Dianas Terapéuticas
    Aplicación de la biología de sistemas al estudio de la malaria y búsqueda de biomarcadores y dianas terapéuticas Autora: Mireia Ferrer Almirall Máster en Bioinformática y Bioestadística Area 1-Bioinformática farmacéutica Tutores: Melchor Sánchez Martínez y Alex Sánchez Pla Profesor responsable de la asignatura: Carles Ventura Royo 02/01/2019 Esta obra está sujeta a una licencia de Reconocimiento-NoComercial- SinObraDerivada 3.0 España de Creative Commons FICHA DEL TRABAJO FINAL Aplicación de la biología de sistemas al Título del trabajo: estudio de la malaria y búsqueda de biomarcadores y dianas terapéuticas Nombre del autor: Mireia Ferrer Almirall Melchor Sánchez Martínez y Nombre del consultor/a: Alex Sánchez Pla Nombre del PRA: Carles Ventura Royo Fecha de entrega (mm/aaaa): 01/2019 Titulación: Máster en Bioinformática y Bioestadística Área del Trabajo Final: 1-Bioinformática farmacéutica Idioma del trabajo: castellano Malaria, Biología-de-sistemas, Palabras clave dianas-terapéuticas Resumen del Trabajo (máximo 250 palabras): Con la finalidad, contexto de aplicación, metodología, resultados i conclusiones del trabajo. La finalidad de este trabajo es aplicar herramientas de biología de sistemas para investigar los mecanismos implicados en la infección por el parásito de la malaria e identificar posibles biomarcadores y dianas terapéuticas. Se ha partido de una serie temporal de datos de microarrays del bazo de ratones infectados con dos cepas del parásito (NL y L) para determinar los genes que se encuentran diferencialmente expresados (DEG) respecto a ratones control. A partir de las listas de DEG obtenidas, se han utilizado herramientas de biología de sistemas en combinación con análisis de significación biológica para obtener una visión integrada de los procesos biológicos que se encuentran alterados en la enfermedad e identificar posibles biomarcadores/dianas terapéuticas.
    [Show full text]
  • Differential Features of Fusion Activation Within the Paramyxoviridae
    viruses Review Differential Features of Fusion Activation within the Paramyxoviridae Kristopher D. Azarm and Benhur Lee * Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-212-241-2552 Received: 17 December 2019; Accepted: 29 January 2020; Published: 30 January 2020 Abstract: Paramyxovirus (PMV) entry requires the coordinated action of two envelope glycoproteins, the receptor binding protein (RBP) and fusion protein (F). The sequence of events that occurs during the PMV entry process is tightly regulated. This regulation ensures entry will only initiate when the virion is in the vicinity of a target cell membrane. Here, we review recent structural and mechanistic studies to delineate the entry features that are shared and distinct amongst the Paramyxoviridae. In general, we observe overarching distinctions between the protein-using RBPs and the sialic acid- (SA-) using RBPs, including how their stalk domains differentially trigger F. Moreover, through sequence comparisons, we identify greater structural and functional conservation amongst the PMV fusion proteins, as compared to the RBPs. When examining the relative contributions to sequence conservation of the globular head versus stalk domains of the RBP, we observe that, for the protein-using PMVs, the stalk domains exhibit higher conservation and find the opposite trend is true for SA-using PMVs. A better understanding of conserved and distinct features that govern the entry of protein-using versus SA-using PMVs will inform the rational design of broader spectrum therapeutics that impede this process. Keywords: paramyxovirus; viral envelope proteins; type I fusion protein; henipavirus; virus entry; viral transmission; structure; rubulavirus; parainfluenza virus 1.
    [Show full text]